'Hepatitis' means inflammation of the liver and is caused by one of a number of viruses. Hepatitis C is the most common form of hepatitis amongst injecting drug users. Often people who are infected with Hep C do not realise they have the virus because they do not experience symptoms. Some people (around 20%) recover completely from the infection; the rest (80%) are infected for life, although they may not feel ill for many years; 510% will develop serious liver disease such as cirrhosis (scarring) or liver cancer in the long term.
There are currently about 200,000 Australians infected with the Hep C virus, with an estimated 11,000 new infections occurring each year. The majority of new cases of Hep C infection are due to unsafe injecting practices.
Hepatitis A is usually a mild disease that does not become chronic (i.e. cause long-term health problems). It is passed on via food and water contaminated with faeces (shit) from an infected person and occasionally via oral/anal sexual contact.
Hepatitis B is a blood borne virus which is transmitted via blood and other body fluids including saliva, semen, vaginal secretions and breast milk. It is
not
passed on via water contamination or in food. It becomes chronic for a small proportion of adults and almost all small children who are infected.
Hepatitis C is also a blood borne virus; however, unlike Hep B it is found only in blood. It is
not
considered a sexually transmitted infection and cases of Hep C transmission involving sexual contact also involve quantities of blood. It is
not
transmitted via food or water contamination. It becomes chronic (i.e. long term) for about three-quarters of all people infected with the virus.
There are several strains or genotypes of Hep C as well as different subtypes of each strain. These strains are different in their genetic make-up, but are similar enough to still be labelled Hep C. There are six different genotypes (or strains) of the Hep C virus (1 to 6), with the prevalence of different genotypes varying from country to country, for example genotypes 1 and 3 are most common in Australia. It is possible for users who continue high-risk practices to be infected with a different strain or be re-infected with the same strain.
There are vaccines for both Hep A and B; however, there is
no
vaccine for Hep C.